Erasca, Inc.
ERASNASDAQHealthcare● Active
$12.87
+$0.90(+7.52%)
Market Cap$4.0B
P/E Ratio—
52W High$24.28
52W Low$1.21
Erasca, Inc. (ERAS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ERAS · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 11, 2026EPS Actual
-$0.11
Est. -$0.12 · +4.7%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 11, 2026
After Market Close
▲ Beat EPS🔥 7-Quarter EPS Beat Streak
ERAS reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 11, 2026 | -$0.12 | — | — | — | — | — |
| ▲ Q2 FY2026 | May 11, 2026 | -$0.12 | -$0.11 | +4.7% | — | — | — |
| ▲ Q1 FY2026 | Mar 12, 2026 | -$0.11 | -$0.10 | +9.1% | — | — | — |
| — Q4 FY2025 | Nov 12, 2025 | -$0.11 | -$0.11 | +0.0% | — | — | — |
| — Q3 FY2025 | Aug 12, 2025 | -$0.12 | -$0.12 | +0.0% | — | — | — |
| ▲ Q2 FY2025 | May 13, 2025 | -$0.12 | -$0.11 | +8.3% | — | — | — |
| ▲ Q1 FY2025 | Mar 20, 2025 | -$0.12 | -$0.11 | +8.3% | — | — | — |
| ▲ Q4 FY2024 | Nov 12, 2024 | -$0.17 | -$0.11 | +35.3% | — | — | — |
Q3 FY2026
Aug 11, 2026
EPS Actual
—
EPS Est.
-$0.12
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 11, 2026Beat
EPS Actual
-$0.11
EPS Est.
-$0.12
EPS Surpr.
+4.7%
Revenue
—
Q1 FY2026
Mar 12, 2026Beat
EPS Actual
-$0.10
EPS Est.
-$0.11
EPS Surpr.
+9.1%
Revenue
—
Q4 FY2025
Nov 12, 2025
EPS Actual
-$0.11
EPS Est.
-$0.11
EPS Surpr.
+0.0%
Revenue
—
Q3 FY2025
Aug 12, 2025
EPS Actual
-$0.12
EPS Est.
-$0.12
EPS Surpr.
+0.0%
Revenue
—
Q2 FY2025
May 13, 2025Beat
EPS Actual
-$0.11
EPS Est.
-$0.12
EPS Surpr.
+8.3%
Revenue
—
Q1 FY2025
Mar 20, 2025Beat
EPS Actual
-$0.11
EPS Est.
-$0.12
EPS Surpr.
+8.3%
Revenue
—
Q4 FY2024
Nov 12, 2024Beat
EPS Actual
-$0.11
EPS Est.
-$0.17
EPS Surpr.
+35.3%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.15 | $-0.15 | $-0.15 | 2 |
| Q3 FY2027 | $-0.14 | $-0.14 | $-0.14 | 2 |
| Q2 FY2027 | $-0.14 | $-0.14 | $-0.14 | 2 |
| Q1 FY2027 | $-0.13 | $-0.13 | $-0.13 | 2 |
| Q4 FY2026 | $-0.13 | $-0.13 | $-0.13 | 4 |
| Q3 FY2026 | $-0.13 | $-0.12 | $-0.12 | 6 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 11, 2026 | +4.7% | $10.12 | $10.44 | +3.16% |
| ▲ Q1 FY2026 | Mar 12, 2026 | +9.1% | $15.50 | $14.65 | -5.48% |
| ▲ Q4 FY2025 | Nov 12, 2025 | +0.0% | $2.36 | $2.65 | +12.29% |
| ▲ Q3 FY2025 | Aug 12, 2025 | +0.0% | $1.48 | $1.56 | +5.41% |
| ▲ Q2 FY2025 | May 13, 2025 | +8.3% | $1.39 | $1.33 | -4.32% |
| ▲ Q1 FY2025 | Mar 20, 2025 | +8.3% | $1.48 | $1.48 | +0.00% |
| ▲ Q4 FY2024 | Nov 12, 2024 | +35.3% | $3.11 | $2.99 | -3.86% |
| ▼ Q3 FY2024 | Aug 12, 2024 | -70.6% | $2.40 | $2.59 | +7.92% |
Q2 FY2026+3.16%
Report Date
May 11, 2026
EPS Beat/Miss
+4.7%
Price Before
$10.12
Price After
$10.44
Q1 FY2026-5.48%
Report Date
Mar 12, 2026
EPS Beat/Miss
+9.1%
Price Before
$15.50
Price After
$14.65
Q4 FY2025+12.29%
Report Date
Nov 12, 2025
EPS Beat/Miss
+0.0%
Price Before
$2.36
Price After
$2.65
Q3 FY2025+5.41%
Report Date
Aug 12, 2025
EPS Beat/Miss
+0.0%
Price Before
$1.48
Price After
$1.56
Q2 FY2025-4.32%
Report Date
May 13, 2025
EPS Beat/Miss
+8.3%
Price Before
$1.39
Price After
$1.33
Q1 FY2025+0.00%
Report Date
Mar 20, 2025
EPS Beat/Miss
+8.3%
Price Before
$1.48
Price After
$1.48
Q4 FY2024-3.86%
Report Date
Nov 12, 2024
EPS Beat/Miss
+35.3%
Price Before
$3.11
Price After
$2.99
Q3 FY2024+7.92%
Report Date
Aug 12, 2024
EPS Beat/Miss
-70.6%
Price Before
$2.40
Price After
$2.59
Avg Beat Reaction+1.03%
Avg Miss Reaction+7.92%
Beat Rate7 / 8 quarters
Largest Move+12.29% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ERAS ends December
Erasca, Inc. (ERAS) most recently reported earnings on May 11, 2026 for Q2 FY2026, posting EPS of $-0.11 — beating the analyst consensus of $-0.12 by +4.7%. ERAS has beaten EPS estimates for 7 consecutive quarters. The next ERAS earnings date is expected around September 1, 2026.
Each quarter, investors track ERAS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ERAS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ERAS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ERAS earnings · 5 questionsErasca, Inc.'s next earnings report is expected around September 1, 2026. ERAS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ERAS historically reports after market close (AMC).
ERAS earnings datewhen is ERAS earningsERAS next earnings datewhen does ERAS report earningsERAS earnings calendar
▸ Source: FMP · Erasca, Inc. SEC filings · US GAAP · Erasca, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026